Your browser doesn't support javascript.
loading
Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression.
Mansur, Rodrigo B; Subramaniapillai, Mehala; Lee, Yena; Pan, Zihang; Carmona, Nicole E; Shekotikhina, Margarita; Iacobucci, Michelle; Rodrigues, Nelson; Nasri, Flora; Rashidian, Houman; Rosenblat, Joshua D; Brietzke, Elisa; Cosgrove, Victoria E; Kramer, Nicole E; Suppes, Trisha; McIntyre, Roger S.
Afiliação
  • Mansur RB; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address: rodrigo.mansur@uhn.ca.
  • Subramaniapillai M; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
  • Lee Y; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Pan Z; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
  • Carmona NE; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychology, Ryerson University, Toronto, ON, Canada.
  • Shekotikhina M; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; University of Ottawa, Department of Psychiatry, Ottawa, ON, Canada.
  • Iacobucci M; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
  • Rodrigues N; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
  • Nasri F; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
  • Rashidian H; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Rosenblat JD; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Brietzke E; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Kingston General Hospital, Providence Care Hospital, Department of Psychiatry, Queen's University School of Medicine, Kingston, ON, Canada.
  • Cosgrove VE; Department of Psychiatry & Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, CA, USA.
  • Kramer NE; Department of Psychiatry & Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, CA, USA.
  • Suppes T; Department of Psychiatry & Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, CA, USA.
  • McIntyre RS; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
Psychoneuroendocrinology ; 120: 104779, 2020 10.
Article em En | MEDLINE | ID: mdl-32603956
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Cognição / Leptina Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Psychoneuroendocrinology Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Bipolar / Cognição / Leptina Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Psychoneuroendocrinology Ano de publicação: 2020 Tipo de documento: Article